Clinical Trial Update: Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating weekly paclitaxel plus carboplatin as preoperative therapy for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED